Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2016

09.06.2016 | Review Article

Primary Follicular Lymphoma of the Gastrointestinal Tract: Case Report and Review

verfasst von: Brian T. Moy, Jonathan Wilmot, Enrique Ballesteros, Faripour Forouhar, Haleh Vaziri

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Primary gastrointestinal follicular lymphoma (GI-FL) is considered a rare disease with fewer than 400 cases reported in the literature. It accounts for roughly 1–3 % of GI non-Hodgkins lymphomas (NHL). It originates in the GI tract and typically affects small bowel. The disease has an indolent course, and a prolonged survival can be expected in most cases. Due to its rarity, an optimal diagnostic work up and treatment plan has not been well established.

Methods

Endoscopic evaluation of the entire gastrointestinal (GI) tract using esophagogastroduodenoscopy (EGD), wireless capsule endoscopy, double-balloon enteroscopy, colonoscopy, and whole body examination with fluorodeoxyglucose-positron emission tomography (FDG-PET) has been suggested to more accurately stage the disease and guide the treatment plan.

Results

Treatment options for GI follicular lymphoma include watch and wait strategy, surgery, chemotherapy, radiation, immuno-radiotherapy, or a combination of these modalities.

Conclusion

In this article, we have summarized the existing information regarding clinical presentation, diagnostic evaluation, and treatment options for this rare entity after presenting a case of GI-FL who was diagnosed during an EGD for evaluation of belching, heartburn, and weight loss.
Literatur
1.
Zurück zum Zitat Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9(7):717–20.PubMedCrossRef Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9(7):717–20.PubMedCrossRef
2.
Zurück zum Zitat Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J surg. 1961;49:80–9.PubMedCrossRef Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J surg. 1961;49:80–9.PubMedCrossRef
3.
Zurück zum Zitat Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693–707.PubMedCrossRef Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693–707.PubMedCrossRef
4.
Zurück zum Zitat Lebrun DPKO, Cleary ML. Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol. 1992;140:1327–35.PubMedPubMedCentral Lebrun DPKO, Cleary ML. Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. Am J Pathol. 1992;140:1327–35.PubMedPubMedCentral
5.
Zurück zum Zitat Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Anna Oncol. 2003;14(4):623–9.CrossRef Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Anna Oncol. 2003;14(4):623–9.CrossRef
6.
Zurück zum Zitat Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol. 2002;26(2):216–24.PubMedCrossRef Shia J, Teruya-Feldstein J, Pan D, et al. Primary follicular lymphoma of the gastrointestinal tract: a clinical and pathologic study of 26 cases. Am J Surg Pathol. 2002;26(2):216–24.PubMedCrossRef
10.
Zurück zum Zitat D’Amore F, Christensen BE, Brincker H, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer (Oxford, England : 1990). 1991;27(10):1201–8.CrossRef D’Amore F, Christensen BE, Brincker H, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer (Oxford, England : 1990). 1991;27(10):1201–8.CrossRef
11.
Zurück zum Zitat Cirillo M, Federico M, Curci G, Tamborrino E, Piccinini L, Silingardi V. Primary gastrointestinal lymphoma: a clinicopathological study of 58 cases. Haematologica. 1992;77(2):156–61.PubMed Cirillo M, Federico M, Curci G, Tamborrino E, Piccinini L, Silingardi V. Primary gastrointestinal lymphoma: a clinicopathological study of 58 cases. Haematologica. 1992;77(2):156–61.PubMed
12.
Zurück zum Zitat Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462–73. doi:10.1002/cncr.11415.PubMedCrossRef Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462–73. doi:10.​1002/​cncr.​11415.PubMedCrossRef
13.
Zurück zum Zitat Koh PK, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW. Localised extranodal non-Hodgkin’s lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989–1998). Int J Oncol. 2001;18(4):743–8.PubMed Koh PK, Horsman JM, Radstone CR, Hancock H, Goepel JR, Hancock BW. Localised extranodal non-Hodgkin’s lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989–1998). Int J Oncol. 2001;18(4):743–8.PubMed
14.
Zurück zum Zitat Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993;67(4):776–82.PubMedPubMedCentralCrossRef Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993;67(4):776–82.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Yoshino T, Miyake K, Ichimura K, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol. 2000;24(5):688–93.PubMedCrossRef Yoshino T, Miyake K, Ichimura K, et al. Increased incidence of follicular lymphoma in the duodenum. Am J Surg Pathol. 2000;24(5):688–93.PubMedCrossRef
19.
22.
Zurück zum Zitat Bende RJ, Smit LA, Bossenbroek JG, et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol. 2003;162(1):105–13.PubMedPubMedCentralCrossRef Bende RJ, Smit LA, Bossenbroek JG, et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol. 2003;162(1):105–13.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat de Leon ED, Alkan S, Huang JC, Hsi ED. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin’s lymphomas of small lymphocytes. Mod Pathol. 1998;11(11):1046–51.PubMed de Leon ED, Alkan S, Huang JC, Hsi ED. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin’s lymphomas of small lymphocytes. Mod Pathol. 1998;11(11):1046–51.PubMed
24.
Zurück zum Zitat Harris NL FJ (2001) Folicular lymphoma:823-853 Harris NL FJ (2001) Folicular lymphoma:823-853
26.
Zurück zum Zitat Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985;41(3):899–906.PubMedCrossRef Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985;41(3):899–906.PubMedCrossRef
27.
Zurück zum Zitat Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47(1):19–28.PubMedCrossRef Cleary ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986;47(1):19–28.PubMedCrossRef
28.
Zurück zum Zitat Rohatiner A, D’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400.PubMed Rohatiner A, D’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397–400.PubMed
29.
Zurück zum Zitat Takata K, Sato Y, Nakamura N, et al. Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol. 2009;22(7):940–9. doi:10.1038/modpathol.2009.51.PubMedCrossRef Takata K, Sato Y, Nakamura N, et al. Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. Mod Pathol. 2009;22(7):940–9. doi:10.​1038/​modpathol.​2009.​51.PubMedCrossRef
33.
Zurück zum Zitat Higuchi N, Sumida Y, Nakamura K, et al. Impact of double-balloon endoscopy on the diagnosis of jejunoileal involvement in primary intestinal follicular lymphomas: a case series. Endoscopy. 2009;41(2):175–8. doi:10.1055/s-0028-1119467.PubMedCrossRef Higuchi N, Sumida Y, Nakamura K, et al. Impact of double-balloon endoscopy on the diagnosis of jejunoileal involvement in primary intestinal follicular lymphomas: a case series. Endoscopy. 2009;41(2):175–8. doi:10.​1055/​s-0028-1119467.PubMedCrossRef
34.
Zurück zum Zitat Tanaka F, Tominaga K, Ochi M, et al. Primary duodenal lymphoma: successful rituximab treatment and evaluation by FDG-PET. Hepato-Gastroenterology. 2007;54(78):1658–61.PubMed Tanaka F, Tominaga K, Ochi M, et al. Primary duodenal lymphoma: successful rituximab treatment and evaluation by FDG-PET. Hepato-Gastroenterology. 2007;54(78):1658–61.PubMed
35.
Zurück zum Zitat Hoffmann M, Chott A, Puspok A, Jager U, Kletter K, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum. Ann Hematol. 2004;83(5):276–8. doi:10.1007/s00277-003-0827-6.PubMedCrossRef Hoffmann M, Chott A, Puspok A, Jager U, Kletter K, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum. Ann Hematol. 2004;83(5):276–8. doi:10.​1007/​s00277-003-0827-6.PubMedCrossRef
37.
Zurück zum Zitat Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES, Devita Jr VT. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Semin Hematol. 1988;25(2 Suppl 2):11–6.PubMed Young RC, Longo DL, Glatstein E, Ihde DC, Jaffe ES, Devita Jr VT. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. Semin Hematol. 1988;25(2 Suppl 2):11–6.PubMed
38.
Zurück zum Zitat Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 1997;15(3):1110–7.PubMed Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d’Etude des Lymphomes Folliculaires. Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 1997;15(3):1110–7.PubMed
39.
Zurück zum Zitat Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favorable histologic types. Ann Intern Med. 1979;90(1):10–3.PubMedCrossRef Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin’s lymphomas of favorable histologic types. Ann Intern Med. 1979;90(1):10–3.PubMedCrossRef
42.
Zurück zum Zitat Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106(12):3725–32. doi:10.1182/blood-2005-01-0016.PubMedCrossRef Hiddemann W, Kneba M, Dreyling M, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106(12):3725–32. doi:10.​1182/​blood-2005-01-0016.PubMedCrossRef
43.
Zurück zum Zitat Herold M, Haas A, Srock S, et al. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. J Clin Oncol. 2007;25(15):1986–92. doi:10.1200/jco.2006.06.4618.PubMedCrossRef Herold M, Haas A, Srock S, et al. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study. J Clin Oncol. 2007;25(15):1986–92. doi:10.​1200/​jco.​2006.​06.​4618.PubMedCrossRef
44.
Zurück zum Zitat Witzig TE, Vukov AM, Habermann TM, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin’s lymphoma: a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol. 2005;23(6):1103–8. doi:10.1200/jco.2005.12.052.PubMedCrossRef Witzig TE, Vukov AM, Habermann TM, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin’s lymphoma: a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol. 2005;23(6):1103–8. doi:10.​1200/​jco.​2005.​12.​052.PubMedCrossRef
45.
Zurück zum Zitat Ardeshna KM, Qian W, Smith P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol. 2014;15(4):424–35. doi:10.1016/s1470-2045(14)70027-0.PubMedCrossRef Ardeshna KM, Qian W, Smith P, et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol. 2014;15(4):424–35. doi:10.​1016/​s1470-2045(14)70027-0.PubMedCrossRef
50.
Zurück zum Zitat Scholz CW, Pinto A, Linkesch W, et al. (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial. J Clin Oncol. 2013;31(3):308–13. doi:10.1200/jco.2011.41.1553.PubMedCrossRef Scholz CW, Pinto A, Linkesch W, et al. (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial. J Clin Oncol. 2013;31(3):308–13. doi:10.​1200/​jco.​2011.​41.​1553.PubMedCrossRef
51.
Zurück zum Zitat Schmatz AI, Streubel B, Kretschmer-Chott E, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. 2011;29(11):1445–51. doi:10.1200/jco.2010.32.9193.PubMedCrossRef Schmatz AI, Streubel B, Kretschmer-Chott E, et al. Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol. 2011;29(11):1445–51. doi:10.​1200/​jco.​2010.​32.​9193.PubMedCrossRef
Metadaten
Titel
Primary Follicular Lymphoma of the Gastrointestinal Tract: Case Report and Review
verfasst von
Brian T. Moy
Jonathan Wilmot
Enrique Ballesteros
Faripour Forouhar
Haleh Vaziri
Publikationsdatum
09.06.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2016
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9847-z

Weitere Artikel der Ausgabe 3/2016

Journal of Gastrointestinal Cancer 3/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.